COVID-19 – Does This Disease Kill Due to Imbalance of the Renin Angiotensin System (RAS) Caused by Genetic and Gender Differences in the Response to Viral ACE 2 Attack?

2020, Zhonghua Liu Xing Bing Xue Za Zhi, 41, 145

Wevers, 2010, Renin-angiotensin system in human coronavirus pathogenesis, Future Virol, 5, 145, 10.2217/fvl.10.4

Dijkman, 2012, Replication dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by human coronavirus NL63, J Gen Virol, 93, 1924, 10.1099/vir.0.043919-0

Luo, 2019, Association of ACE2 genetic polymorphisms with hypertension-related target organ damages in south Xinjiang, Hypertens Res, 42, 681, 10.1038/s41440-018-0166-6

Sayed-Tabatabaei, 2006, ACE polymorphisms, Circ Res, 98, 1123, 10.1161/01.RES.0000223145.74217.e7

Mehra, 2020, Cardiovascular disease, Drug therapy, and mortality in Covid-19, N Engl J Med, 382, e102, 10.1056/NEJMoa2007621

Zaman, 2020, Cardiovascular disease and COVID-19: Australian/New Zealand consensus statement, Med J Aust, 10.5694/mja2.50714

Reynolds, 2020, Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19, N Engl J Med, 382, 2441, 10.1056/NEJMoa2008975

Mancia, 2020, Renin-angiotensin-aldosterone system blockers and the risk of Covid-19, N Engl J Med, 382, 2431, 10.1056/NEJMoa2006923

Gurwitz, 2020, Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics, Drug Dev Res, 10.1002/ddr.21656

Brojakowska, 2020, Clinical implications of SARS-Cov2 interaction with renin angiotensin system: JACC review topic of the week, J Am Coll Cardiol, 75, 3085, 10.1016/j.jacc.2020.04.028

Lau FH, Majumder R, Torabi R, Saeg F, Hoffman R, Cirillo JD, et al. Vitamin D insufficiency is prevalent in severe COVID-19. MedRxiv preprint. https://doi.org/10.1101/2020.04.24.20075838.

Bernstein, 2018, Angiotensin-converting enzyme in innate and adaptive immunity, Nat Rev Nephrol, 14, 325, 10.1038/nrneph.2018.15

Lippi, 2020, Meta-analysis on troponin I in patients with Coronavirus disease 2019 (COVID-10): evidence from a meta-analysis, Prog Cardiovasc Dis Mar, 10

Patel, 2016, Role of the ACE2/Angiotensin 1-7 axis of the renin-angiotensin system in heart failure, Circ Res, 118, 1313, 10.1161/CIRCRESAHA.116.307708

Epelman, 2008, Detection of soluble angiotensin-converting enzyme 2 in heart failure, J Am Coll Cardiol, 52, 750, 10.1016/j.jacc.2008.02.088

Vaduganathan, 2020, Renin-angiotensin-aldosterone system inhibitors in patients with COVID-19, N Engl J Med, 382, 17, 10.1056/NEJMsr2005760

Patel, 2020, COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence?, JAMA, 10.1001/jama.2020.4812

Sommerstein, 2020, Coronavirus disease 2019 (COVID-19): do angiotensin-converting enzyme inhibitors/angiotensin receptor blockers have a biphasic effect?, J Am Heart Assoc, 9, e016509, 10.1161/JAHA.120.016509

Wang, 2020, Angiotensin converting enzyme 2: a double-edged sword, Circulation

Zhang, 2020, Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin ii receptor blockers with mortality among patients with hypertension hospitalized with COVID-19, Circ Res, 126, 1671, 10.1161/CIRCRESAHA.120.317134

Bean, 2020, Treatment with ACE-inhibitors is associated with less severe disease with SARS-Covid-19 infection in a multi-site UK acute hospital trust, MedRxiv

Patel, 2012, Association of ACE2 Genetic variants with blood pressure, left ventricular mass and cardiac function in Caucasians with type 2 diabetes, Am J Hypertens, 25, 216, 10.1038/ajh.2011.188

Bukowska, 2017, Protective regulation of the ACE2/ACE gene expression by estrogen in human atrial tissue from elderly men, Exp Biol Med (Maywood), 242, 1412, 10.1177/1535370217718808

Ghosh, 2017, Sex drives dimorphic immune responses to viral infections, J Immunol, 198, 178, 10.4049/jimmunol.1601166

Oakes, 2018, Nicotine and the renin angiotensin system, Am J Physiol Regul Integr Comp Physiol, 315, R895, 10.1152/ajpregu.00099.2018

Huang, 2020, Clinical Features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5

Guan, 2020, China Medical Treatment Expert Group for Covid-19. Clinical characteristics of Coronavirus disease 2019 in China, N Engl J Med, 382, 1708, 10.1056/NEJMoa2002032

Zhang, 2020, Clinical characteristics of 140 patients infected with SARS-CoV in Wuhan, China, Allergy, 10.1111/all.14238

Reddy, 2019, Soluble neprilysin in the general population: clinical determinants and its relationship to cardiovascular disease, J Am Heart Assoc, 8, e012943, 10.1161/JAHA.119.012943

Chen D, Li X, Song Q, Hu C, Su F, Dai J. Hypokalemia and clinical implications in patients with Coronavirus Disease 2019 (COVID-19), MedRxiv, https://doi.org/10.1101/2020.02.27.20028530

Fox SE, Akmatbekov A, Harbert JL, Li Q, Brown Q, Vender Heide RS. Pulmonary and cardiac pathology in COVID-19: the first autopsy series from New Orleans. MedRxiv, https://doi.org/10.1101/2020.04.06.20050575

Guo, 2020, J Am Heart Assoc, 9, e016219, 10.1161/JAHA.120.016219

New York Times, 2020

Zhang, 2019, Host lipids in positive-strand RNA virus genome replication, Front Microbiol, 10, 286, 10.3389/fmicb.2019.00286

Yan, 2019, Characterization of lipidomic profile of human coronavirus-infected cells: Implications for lipid metabolism remodelling upon coronavirus replication, Viruses, 11, 73, 10.3390/v11010073

Arifin, 2016, Lysophosphatidylinositol signalling and metabolic diseases, Metabolites, 6, 6, 10.3390/metabo6010006

Moldofsky, 2011, Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study, BMC Neurol, 11, 37, 10.1186/1471-2377-11-37

Wu, 2017, Altered lipid metabolism in recovered SARS patients twelve years after infection, Sci Rep, 7, 9110, 10.1038/s41598-017-09536-z

Zhang, 2020, Long term bone and lung consequences associated with hospital -acquired severe acute respiratory syndrome: a 15 year follow-up from a prospective cohort study, Bone Res, 8, 8, 10.1038/s41413-020-0084-5

Yang, 2005, Autoantibodies against human epithelial cells and endothelial cells after severe acute respiratory syndrome (SARS)-associated coronavirus infection, J Med Virol, 77, 1, 10.1002/jmv.20407

Grant, 2020, Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths, Nutrients, 12, E988, 10.3390/nu12040988

Wang, 2020, Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial, Lancet, 395, 1569, 10.1016/S0140-6736(20)31022-9

Li, 2020, Updated approaches against SARS-CoV-2, Antimicrob Agents Chemother, 64, 10.1128/AAC.00483-20